Globe Newswire NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ( Anavex or the Company ) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...\n more…
Ticker Report SG Americas Securities LLC acquired a new stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the...\n more…
Ticker Report Anavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 19,880,000 shares, a growth...\n more…
Seeking Alpha: Transcripts Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript...\n more…